A comprehensive transcriptional portrait of human cancer cell lines

Christiaan Klijn1, Steffen Durinck2, Eric W Stawiski2

  • 1Department of Bioinformatics and Computational Biology, Genentech Inc., South San Francisco, California, USA.

Nature Biotechnology
|December 9, 2014
PubMed

Insights

This study analyzes the transcriptomes of 675 cancer cell lines, revealing novel gene fusions and improving predictions for targeted cancer therapies. The findings offer a valuable resource for cancer research using cell line models.

Area of Science:

  • Oncology
  • Genomics
  • Transcriptomics

Background:

  • Cancer cell lines are crucial for understanding oncogene function and drug responses.
  • Genomic characterization of cell lines is extensive, but transcriptomic data is less explored.

Purpose of the Study:

  • To comprehensively analyze the transcriptome of 675 human cancer cell lines.
  • To identify novel gene fusions and assess transcriptome features for therapeutic response prediction.

Main Methods:

  • RNA sequencing and single-nucleotide polymorphism (SNP) array analysis were performed on 675 cancer cell lines.
  • Transcriptome features including gene expression, mutations, and gene fusions were analyzed.
  • A pathway-based approach combined genomic and transcriptomic data.

Main Results:

  • Catalogued 2,200 gene fusions, with 1,435 involving previously unfused genes.
  • Comprehensive analysis of gene expression, mutations, and non-human sequences.
  • Enhanced prediction of targeted therapeutic responses by integrating multiple data types.

Conclusions:

  • The study provides a rich transcriptomic dataset for 675 human cancer cell lines.
  • Identified numerous novel gene fusions with potential implications for cancer biology.
  • The integrated approach improves the predictive power for targeted cancer therapies.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.1K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
16.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.9K